Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance

References

• Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376(26):2566–2578.
   PubMed Web of Science ®Google Scholar
• Sultan S, Malhotra A. Irritable bowel syndrome. Ann Intern Med. 2017;166(11):ITC81–ITC96.
   PubMed Web of Science ®Google Scholar
• Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterology and motility: the official journal of the. Neurogastroenterol Motil. 2015;27(4):481–489.
   PubMed Web of Science ®Google Scholar
• Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11(8):497–505.
   PubMed Web of Science ®Google Scholar
• Chen B, Kim JJ, Zhang Y, et al. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol. 2018;53(7):807.
   PubMed Web of Science ®Google Scholar
• Ding XW, Liu YX, Fang XC, et al. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017(21):5191–5196.
   Google Scholar
• Scarpellini Vg E, Gabrielli M, Filoni* S, et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome: a preliminary study. Eur Rev Med Pharmacol Sci. 2013;17:1314–1320.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Srivastava D, Misra A, et al. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016;28(3):281–289.
   PubMed Web of Science ®Google Scholar
• Jung SE, Joo NS, Han KS, et al. Obesity is inversely related to Hydrogen-producing small intestinal bacterial overgrowth in Non-constipation irritable bowel syndrome. J Korean Med Sci. 2017;32(6):948–953.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-based breath testing in gastrointestinal disorders: the north american consensus. Am J Gastroenterol. 2017;112(5):775–784.
   PubMed Web of Science ®Google Scholar
• Tap J, Derrien M, Tornblom H, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152(1):111–123 e8.
   PubMed Web of Science ®Google Scholar
• Adike A, DiBaise JK. Small intestinal bacterial overgrowth. Gastroenterol Clin N Am. 2018;47(1):193–208.
   PubMed Web of Science ®Google Scholar
• Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–958.
   PubMed Web of Science ®Google Scholar
• Rajilic-Stojanovic M, Jonkers DM, Salonen A, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol. 2015;110(2):278–287.
   PubMed Web of Science ®Google Scholar
• Jeffery IB, O'Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61(7):997–1006.
   PubMed Web of Science ®Google Scholar
• Chung CS, Chang PF, Liao CH, et al. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol. 2016;51(4):410–419.
   PubMed Web of Science ®Google Scholar
• Lasa JS, Zubiaurre I, Fanjul I, et al. Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients. Rev Gastroenterol Mex. 2015;80(2):171–174.
   PubMed Web of Science ®Google Scholar
• Park JH, Park DI, Kim HJ, et al. The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome. Gut Liver. 2009;3(3):174–179.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Park S, Low K, et al. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterology. 2007;102(4):837–841.
   PubMed Web of Science ®Google Scholar
• Kunkel D, Basseri RJ, Makhani MD, et al. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56(6):1612–1618.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18(2):8.
   PubMedGoogle Scholar
• Loh G, Blaut M. Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes. 2012;3(6):544–555.
   PubMed Web of Science ®Google Scholar
• Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World J Gastroenterol. 2014;20(10):2482–2491.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang L, Wang X, et al. Similar fecal microbiota signatures in patients with Diarrhea-Predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol. 2016;14(11):1602–1611.e5.
   PubMed Web of Science ®Google Scholar
• Dodd D, Mackie RI, Cann IK. Xylan degradation, a metabolic property shared by rumen and human colonic Bacteroidetes. Mol Microbiol. 2011;79(2):292–304.
   PubMed Web of Science ®Google Scholar
• Kovatcheva-Datchary P, Nilsson A, Akrami R, et al. Dietary Fiber-Induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metabolism. 2015;22(6):971–982.
   PubMed Web of Science ®Google Scholar
• Bourdu S, Dapoigny M, Chapuy E, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology. 2005;128(7):1996–2008.
   PubMed Web of Science ®Google Scholar
• Staudacher HM, Irving PM, Lomer MCE, et al. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. 2014;11(4):256–266.
   PubMed Web of Science ®Google Scholar
• Graham C, Mullen A, Whelan K. Obesity and the gastrointestinal microbiota: a review of associations and mechanisms. Nutr Rev. 2015;73(6):376–385.
   PubMed Web of Science ®Google Scholar
• Kasselman LJ, Vernice NA, DeLeon J, et al. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis. 2018;271:203–213.
   PubMed Web of Science ®Google Scholar
• Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal prevotella copri correlates with enhanced susceptibility to arthritis. ELife. 2013;2(2):e01202.
   PubMed Web of Science ®Google Scholar
• Dillon SM, Lee EJ, Kotter CV, et al. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 2016;9(1):24–37.
   PubMed Web of Science ®Google Scholar
• Su T, Liu R, Lee A, et al. Altered intestinal microbiota with increased abundance of prevotella is associated with high risk of diarrhea-predominant irritable bowel syndrome. Gastroenterol Res Pract. 2018;2018:1.
   Web of Science ®Google Scholar